M A Sultan
Department of Infectious Diseases, Rawalpindi Medical University, Rawalpindi, Pakistan.
East Mediterr Health J. 2022 Jul 31;28(7):515-520. doi: 10.26719/emhj.22.045.
The Global Polio Eradication Initiative (GPEI) promised to eradicate polio by 2000, yet the disease remains endemic in 2 countries. The current threat of resurgence in countries with low vaccine coverage and circulating vaccinederived poliovirus (cVDPV) outbreaks due to oral polio vaccine warrants a strategy review.
To review the performance of the GPEI from a context based in Pakistan, identifying threats to success and suggesting strategy modifications to help achieve eradication.
This was a desk review of the effectiveness of GPEI that was launched in 1988 to eradicate polio by 2000. Subsequent failure to eradicate led to multiple iterations in strategy and planning documents. These documents were reviewed alongside relevant literature to explore the reasons for failure and emergence of cVDPV.
GPEI has been effective in reducing the global polio disease burden by > 99%, but it remains endemic in Pakistan and Afghanistan. cVDPV has caused multiple outbreaks since 2000, and caused 7 times more cases than wild poliovirus (WPV) globally in 2020. The Polio Eradication and Endgame Strategic Plan 2013-2018 aimed to eradicate WPV and cVDPV simultaneously. In 2019, Pakistan saw an upsurge in WPV amid an outbreak of cVDPV infection that continued throughout 2020. Wild polio eradication was not realized and the country was unable to transition to inactivated polio vaccine as predicted in the strategic plan.
Over 20 countries now report cVDPV outbreaks and many others are at risk. A country-specific modified strategy is required to eradicate WPV and cVDPV simultaneously, more so in endemic countries.
全球消灭脊髓灰质炎行动(GPEI)曾承诺在2000年根除脊髓灰质炎,但该病仍在两个国家流行。由于口服脊髓灰质炎疫苗导致疫苗衍生脊髓灰质炎病毒(cVDPV)在疫苗接种覆盖率低的国家传播以及爆发疫情,目前脊髓灰质炎有卷土重来的威胁,这就需要对战略进行审查。
从巴基斯坦的背景出发,审查全球消灭脊髓灰质炎行动的成效,确定成功面临的威胁,并提出战略调整建议以助力实现根除目标。
这是一项案头审查,审查了1988年启动的全球消灭脊髓灰质炎行动的成效,该行动原计划在2000年根除脊髓灰质炎。随后未能根除导致战略和规划文件多次修订。对这些文件以及相关文献进行了审查,以探究失败原因和cVDPV的出现情况。
全球消灭脊髓灰质炎行动在将全球脊髓灰质炎疾病负担降低99%以上方面取得了成效,但在巴基斯坦和阿富汗仍呈地方性流行。自2000年以来,cVDPV已引发多次疫情,2020年在全球导致的病例数比野生脊髓灰质炎病毒(WPV)多7倍。《2013 - 2018年脊髓灰质炎根除与终局战略计划》旨在同时根除WPV和cVDPV。2019年,在cVDPV感染疫情持续整个2020年期间,巴基斯坦的WPV病例激增。野生脊髓灰质炎根除目标未能实现,该国也未能按战略计划预期过渡到使用灭活脊髓灰质炎疫苗。
目前有20多个国家报告了cVDPV疫情,其他许多国家也面临风险。需要制定针对具体国家的调整战略,以同时根除WPV和cVDPV,在地方性流行国家更是如此。